We are a company that researches, develops, manufactures, and sells glycoconjugates, such as glycoproteins and glycopeptides. The development of ADCs using glycan linkers is progressing in the pharmaceutical industry, and we are capable of conducting basic research and contract-based research on these products as well as supplying large quantities of API raw materials. We are also conducting new research and development using glycans, including in mRNA vaccines and other macromolecular LNPs. Our in-house glycosylated somatostatin is currently undergoing clinical trials (Phase 2a), and we plan to out-license the technology in the future.
Development of technology for assessing micronutrient intake using hair and provision of analysis services.
Optogenetics is an innovative neural photostimulation technology, with significant contributions from Japanese researchers whose expertise is highly regarded worldwide. Close collaboration with Nagoya Institute of Technology and Kyoto University is advancing the development of high-sensitivity rhodopsins specialized for vision restoration. This technology overcomes the longstanding issue of insufficient light sensitivity in the field of vision restoration. Furthermore, through joint research with Keio University School of Medicine, applied research on the foundational technology is progressing toward the practical realization of the world’s first gene therapy for vision restoration. The goal is to offer new treatment options for patients suffering from blindness or severe visual impairments.
A startup overcoming challenges in exosome purification with proprietary high-purity, high-yield technology, offering end-to-end support from research to manufacturing. It accelerates practical applications in drug discovery, contributing to a new foundation for pharmaceutical development and driving medical innovation.
Elcyo develops innovative autofocal glasses that automatically adjust focus with proprietary lens technology. Leveraging Fresnel Liquid Crystal Lens Technology, Elcyo has made it possible to create glasses that maintain focus at any distance, addressing a wide range of vision challenges across healthcare, entertainment, and beyond.
